Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis

Bone

Volumn 66, Issue , 2014, Pages 306-314

  Huang, Qiang ^a   Gao, Bo ^a   Jie, Qiang ^a   Wei, Bo Yuan ^a   Fan, Jing ^a   Zhang, Hong Yang ^a   Zhang, Jin Kang ^a   Li, Xiao Jie ^a   Shi, Jun ^a   Luo, Zhuo Jing ^a   Yang, Liu ^a   Liu, Jian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone resorbing cytokine; Osteogenesis; Osteoporosis; Ovariectomized mouse; Oxidative damage

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CYTOKINE; GINSENOSIDE RB 2; GLUTATHIONE; HYDROGEN PEROXIDE; INTERLEUKIN 6; MALONALDEHYDE; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; REACTIVE OXYGEN METABOLITE; GINSENOSIDE;

ALP GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOSTEOPOROSIS EFFECT; ANTIOXIDANT ACTIVITY; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MINERALIZATION; CELL PROLIFERATION; CELL PROTECTION; COL1A1 GENE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FEMUR; GENE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LUMBAR VERTEBRA; MOUSE; NONHUMAN; OCN GENE; OPN GENE; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; OXIDATIVE STRESS; STRUCTURE ANALYSIS; TRABECULAR BONE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BONE; CELL DEATH; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ORGAN SIZE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL MODEL; ANTIOSTEOPOROSIS ACTIVITY; CONCENTRATION RESPONSE; DISEASE MODEL; MC3T3 E1 CELL LINE; PROTEIN EXPRESSION;

ANIMALS; BONE AND BONES; BONE RESORPTION; CELL DEATH; CELL LINE; CYTOKINES; CYTOPROTECTION; FEMALE; GENE EXPRESSION REGULATION; GINSENOSIDES; HYDROGEN PEROXIDE; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; ORGAN SIZE; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; OXIDATIVE STRESS; RANK LIGAND; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84904569485     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.06.010     Document Type: Article

References (56)

1. Sanchez-Rodriguez M.A., Ruiz-Ramos M., Correa-Munoz E., Mendoza-Nunez V.M. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 2007, 8:124.
2. Bouillon, Burckhardt R., Christiansen P., Fleisch C., Fujita H.A., Gennari T., et al. Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993, 94:646-650.
3. Sendur O.F., Turan Y., Tastaban E., Serter M. Antioxidant status in patients with osteoporosis: a controlled study. Joint Bone Spine 2009, 76:514-518.
4. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49:1304.
5. Ozgocmen S., Kaya H., Fadillioglu E., Aydogan R., Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 2007, 295:45-52.
6. Ozgocmen S., Kaya H., Fadillioglu E., Yilmaz Z. Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Arch Med Res 2007, 38:196-205.
7. Muthusami S., Ramachandran I., Muthusamy B., Vasudevan G., Prabhu V., Subramaniam V., et al. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta 2005, 360:81-86.
8. Linnane A.W., Eastwood H. Cellular redox regulation and prooxidant signaling systems: a new perspective on the free radical theory of aging. Ann N Y Acad Sci 2006, 1067:47.
9. Manolagas S.C. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 2010, 31:266-300.
10. Theill L.E., Boyle W.J., Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002, 20:795-823.
11. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
12. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002, 2:389-406.
13. Soltanoff C.S., Yang S., Chen W., Li Y.P. Signaling networks that control the lineage commitment and differentiation of bone cells. Crit Rev Eukaryot Gene Expr 2009, 19:1-46.
14. Huang W., Yang S., Shao J., Li Y.P. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 2007, 12:3068-3092.
15. Isomura H., Fujie K., Shibata K., Inoue N., Iizuka T., Takebe G., et al. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 2004, 197:93-100.
16. Lee N.K., Choi Y.G., Baik J.Y., Han S.Y., Jeong D.W., Bae Y.S., et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106:852-859.
17. Lean J.M., Davies J.T., Fuller K., Jagger C.J., Kirstein B., et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 2003, 112:915-923.
18. Lean J.M., Jagger C.J., Kirstein B., Fuller K., Chambers T.J. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 2005, 146:728-735.
19. Arai M., Shibata Y., Pugdee K., Abiko Y., Ogata Y. Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life 2007, 59:27-33.
20. Almeida M., Han L., Martin-Millan M., Plotkin L.I., Stewart S.A., Roberson P.K., et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 2007, 282:27285-27297.
21. Jilka R.L., Almeida M., Ambrogini E., Han L., Roberson P.K., et al. Decreased oxidative stress and greater bone anabolism in the aged, as compared to the young, murine skeleton by parathyroid hormone. Aging Cell 2010, 9:851-867.
22. Ma W.G., Mizutani M., Malterud K.E., Lu S.L., Ducrey B., Tahara S. Saponins from the roots of Panax notoginseng. Phytochemistry 1999, 52:1133-1139.
23. 2 via activation of AMPK. Arch Pharm Res 2011, 34(7):1201-1208.
24. 2 lowers cholesterol and triacylglycerol levels in 3T3-L1 adipocytes cultured under high cholesterol or fatty acids conditions. BMB Rep 2009, 42(4):194-199.
25. 2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur J Gynaecol Oncol 2001, 22(5):339-341.
26. 2 by heat processing. Biol Pharm Bull 2007, 30(4):724-728.
27. 2. Cancer Lett 2000, 152:97-106.
28. 2 extracted from a medicinal plant, Panax ginseng. J Biol Chem 1996, 40:24539-24543.
29. Li Y., Tang L., Duan Y., Ding Y. Up-regulation of MMP-13 and TIMP-1 expression in response to mechanical strain in MC3T3-E1 osteoblastic cells. BMC Res Notes 2010, 3:309.
30. Li Y., Ma W., Feng Z., Wang Z., Zha N., Deng B., et al. Effects of irradiation on osteoblast-like cells on different titanium surfaces in vitro. J Biomed Mater Res B Appl Biomater 2012, 101B:9-17.
31. Boyd Steven K., Davison Peter, Müller Ralph, Gasser Jürg A. Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography. Bone 2006, 39:854-862.
32. Zhang J.K., Yang L., Meng G.L., Yuan Z., Fan J., Li D., et al. Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators. PLoS ONE 2013, 8(2):e57251.
33. Shi Y., Tang B., Yu P.W., Tang B., Hao Y.X., Lei X., et al. Autophagy protects against oxaliplatin-induced cell death via ER stress and ROS in Caco-2 cells. PLoS ONE 2012, 7:e51076.
34. Baek K.H., Oh K.W., Lee W.Y., Lee S.S., Kim M.K., Kwon H.S., et al. Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 2010, 87:226-235.
35. Maggio D., Barabani M., Pierandrei M., Polidori M.C., Catani M., Catani M., et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 2003, 88:1523-1527.
36. Denisova N.A., Cantuti-Castelvetri I., Hassan W.N., Paulson K.E., Joseph J.A. Role of membrane lipids in regulation of vulnerability to oxidative stress in PC12 cells: implication for aging. Free Radic Biol Med 2001, 30:671-678.
37. Liu A.L., Zhang Z.M., Zhu B.F., Liao Z.H., Liu Z. Metallothionein protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation. Cell Biol Int 2004, 28:905-911.
38. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
39. Bai X.C., Lu D., Liu A.L., Zhang Z.M., Li X.M., Zou Z.P., et al. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 2005, 280:17497-17506.
40. Girasole G., Jilka R.L., Passeri G., Boswell S., Boder G., Williams D.C., et al. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992, 89:883-891.
41. Kurihara N., Bertolini D., Suda T., Akiyama Y., Roodman G.D. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 1990, 144:4226-4230.
42. Papanicolaou D.A., Vgontzas A.N. Interleukin-6: the endocrine cytokine. J Clin Endocrinol Metab 2000, 85:1331-1333.
43. Kitazawa R., Kimble R.B., Vannice J.L., Kung V.T., Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 1994, 94:2397-2406.
44. Van der H.A., Burgering B.M. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 2007, 8:440-450.
45. Greer E.L., Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005, 24:7410-7425.
46. Essers M.A., Weijzen S., Vries-Smits A.M., Saarloos I., de Ruiter N.D., Bos J.L., et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 2004, 23:4802-4812.
47. Lehtinen M.K., Yuan Z., Boag P.R., Yang Y., Villen J., Becker E.B., et al. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 2006, 125:987-1001.
48. Wang M.C., Bohmann D., Jasper H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 2005, 121:115-125.
49. Oh S.W., Mukhopadhyay A., Svrzikapa N., Jiang F., Davis R.J., Tissenbaum H.A. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc Natl Acad Sci U S A 2005, 102:4494-4499.
50. Ambrogini E., Almeida M., Martin-Millan M., Paik J.H., DePinho R.A., Han L., et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab 2010, 11(2):136.
51. Cakatay U., Aydin S., Yanar K., Uzun H. Gender-dependent variations in systemic biomarkers of oxidative protein, DNA, and lipid damage in aged rats. Aging Male 2010, 13:51.
52. Estrela J.M., Ortega A., Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 2006, 43:143-181.
53. Kinov P., Leithner A., Radl R., Bodo K., Khoschsorur G.A., Schauenstein K., et al. Role of free radicals in aseptic loosening of hip arthroplasty. J Orthop Res 2006, 24:55-62.
54. Kim T.H., Jung J.W., Ha B.G., Hong J.M., Park E.K., Kim H.J., et al. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. J Nutr Biochem 2011, 22:8-15.
55. Chappard D., Basle M.F., Legrand E., Audran M. Trabecular bone microarchitecture: a review. Morphologie 2008, 92:162-170.
56. Campbell G.M., Buie H.R., Boyd S.K. Signs of irreversible architectural changes occur early in the development of experimental osteoporosis as assessed by in vivo micro-CT. Osteoporos Int 2008, 19:1409-1419.